ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 33779754

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.

Caravaca-Fontán F and 41 others. Nephrol Dial Transplant, 2022. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy. Papers, record 33779754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33779754

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.
PubMed
Journal
Nephrol Dial Transplant
PubMed
Year
2022
PubMed
Publication types
Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
3.78
iCite
Revised in PubMed
2022-07-21
PubMed

Authors42

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caravaca-Fontán FFernando
2Díaz-Encarnación MMontserrat
3Cabello VVirginia
4Ariceta GGema
5Quintana LFLuis Fhttps://orcid.org/0000-0001-7582-8476
6Marco HHelena
7Barros XXoana
8Ramos NNatalia
9Rodríguez-Mendiola NNuria
10Cruz SSonia

1 to 10 of 42Source PubMed

See all 42 authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlomerulonephritisMajor topic
Glomerulonephritis, MembranoproliferativeMajor topic
Kidney Failure, ChronicMajor topic
Adolescent
Adult
Complement C3
Humans
Kidney
Proteinuria
Retrospective Studies
Young Adult

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42,973,604An Italian Delphi consensus on the epidemiology, characteristics, and management of C3 glomerulopathy.Front Immunol2026https://conductscience.org/library/papers/42973604PubMed
42,138,781Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.Adv Ther2026https://conductscience.org/library/papers/42138781PubMed
42,131,278A Narrative Review of C3 Glomerulopathy: From Pathogenesis to Targeted Therapy.Can J Kidney Health Dis2026https://conductscience.org/library/papers/42131278PubMed
41,900,938Prognostic Stratification in Primary Glomerulonephritis: Integrating Histology, Biomarkers, and Risk Prediction Models.Life (Basel)2026https://conductscience.org/library/papers/41900938PubMed
41,783,430C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies.Kidney Med2026https://conductscience.org/library/papers/41783430PubMed
41,767,602Primary membranoproliferative glomerulonephritis: natural history, pathogenesis, and treatment.Front Nephrol2026https://conductscience.org/library/papers/41767602PubMed
41,716,735Real-World Analysis of Patients With C3 Glomerulopathy in the United States.Kidney Int Rep2026https://conductscience.org/library/papers/41716735PubMed
41,502,799Delphi Consensus on Surrogate End Points in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.Kidney Int Rep2026https://conductscience.org/library/papers/41502799PubMed
40,971,335
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review.
Nephron2026https://conductscience.org/library/papers/40971335PubMed
40,512,548Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN.Clin J Am Soc Nephrol2025https://conductscience.org/library/papers/40512548PubMed

1 to 10 of 22

See all 22 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33779754

GET https://conductscience.org/api/papers/v1/33779754/authors?page=2

API referenceFor AI assistants